These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient. Seetharam AB; Borg BB; Subramanian V; Chapman WC; Crippin JS; Mohanakumar T Transplantation; 2011 Dec; 92(12):1364-70. PubMed ID: 22082818 [TBL] [Abstract][Full Text] [Related]
6. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes. Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of recurrent HCV infection after liver transplantation]. Ostojić R Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241 [TBL] [Abstract][Full Text] [Related]
8. Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation. Gao Y; Ren H; Meng F; Li J; Cheung E; Li H; Zhao J; Liu H; Liu Z; Zhang M PLoS One; 2016; 11(4):e0154419. PubMed ID: 27123854 [TBL] [Abstract][Full Text] [Related]
9. [HCV reinfection after liver transplantation for HCV cirrhosis]. Pasquale G; Iannicelli P; Martini S; Mogavero AR; Caprio N Infez Med; 2005 Dec; 13(4):215-28. PubMed ID: 16388277 [TBL] [Abstract][Full Text] [Related]
10. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024 [TBL] [Abstract][Full Text] [Related]
12. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay. Rosen HR; Gretch D; Kaufman E; Quan S Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054 [TBL] [Abstract][Full Text] [Related]
13. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation. Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625 [TBL] [Abstract][Full Text] [Related]
14. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients. Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627 [TBL] [Abstract][Full Text] [Related]
15. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression. Alkhouri N; Hanouneh IA; Lopez R; Zein NN Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483 [TBL] [Abstract][Full Text] [Related]
16. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. Gao Y; Zhang M; Li J; Yang M; Liu Y; Guo X; Li H; Liu Z; Zhao J PLoS One; 2015; 10(9):e0137881. PubMed ID: 26367459 [TBL] [Abstract][Full Text] [Related]